Ekos Supports the Dutch Randomized Trial Comparing Standard Catheter Directed Thrombolysis vs. Ultrasound Accelerated Thrombolysis for Thrombo-Embolic Infra-Inguinal Disease (DUET)

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to compare ultrasound (US) accelerated catheter directed thrombolysis to standard catheter directed thrombolysis in patients with recently thrombosed infra-inguinal native arteries or bypass grafts.